1. Home
  2. DLO vs RLAY Comparison

DLO vs RLAY Comparison

Compare DLO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DLO

DLocal Limited

HOLD

Current Price

$13.60

Market Cap

4.5B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$17.96

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLO
RLAY
Founded
2013
2015
Country
Uruguay
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
DLO
RLAY
Price
$13.60
$17.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$17.25
★ $19.50
AVG Volume (30 Days)
1.4M
★ 2.9M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
★ 1.45%
N/A
EPS Growth
N/A
★ 31.78
EPS
★ N/A
N/A
Revenue
N/A
★ $15,355,000.00
Revenue This Year
$41.00
N/A
Revenue Next Year
$26.98
$324.03
P/E Ratio
$22.27
★ N/A
Revenue Growth
N/A
★ 53.44
52 Week Low
$10.64
$5.17
52 Week High
$16.78
$21.27

Technical Indicators

Market Signals
Indicator
DLO
RLAY
Relative Strength Index (RSI) 35.70 43.01
Support Level $13.14 $11.68
Resistance Level $15.55 $20.29
Average True Range (ATR) 0.37 0.83
MACD -0.11 -0.11
Stochastic Oscillator 0.00 34.28

Price Performance

Historical Comparison
DLO
RLAY

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: